- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
MRI reveals when cognitive impairment will advance
Swiss researchers used susceptibility-weighted MRI and an artificial intelligence technique to help identify which individuals with mild cognitive impairment will continue to decline.
Swiss researchers used susceptibility-weighted MRI and an artificial intelligence technique to help identify which individuals with mild cognitive impairment will continue to decline.
Susceptibility-weighted MRI measures magnetic susceptibility phase-effect differences between tissues. Using the technique, researchers were able to view details of the blood vessels in the brain, including microhemorrhages and microbleeds.
The scans revealed microbleeds in 33% subjects with stable mild cognitive impairment. They found microbleeds in 54% of those with progressive cognitive impairment and in 14% of the control group. The study appeared in Radiology.
The researchers also analyzed the data with support vector technology algorithms to identify patterns within a group and create classifications. By adding the support vector technology to the baseline MRI data the researchers were able to distinguish patients with mild cognitive impairment with 85% accuracy.
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
